Indications for Antibiotics in Eczema Herpeticum

Understanding Eczema Herpeticum

Eczema herpeticum is a disseminated herpes simplex virus (HSV) infection occurring in patients with atopic dermatitis, characterized by multiple discrete vesicles and erosions on areas of pre-existing eczema 3, 4
The primary treatment is systemic antiviral therapy, not antibiotics, as recommended by the American Academy of Dermatology 1, 2
Potential for significant morbidity and mortality if left untreated, with the American Academy of Dermatology emphasizing the importance of prompt treatment 2

Antibiotics should be used in eczema herpeticum only when overt secondary bacterial infection is clinically evident, as indicated by the American Academy of Dermatology 1, 2
Signs of bacterial superinfection, such as purulent exudate or pustules, crusting that appears infected, and systemic signs of infection (fever, elevated inflammatory markers), require antibiotic treatment 2, 5

Flucloxacillin is typically the first-line antibiotic for treating Staphylococcus aureus, the most common pathogen, as recommended by the British Medical Journal 5, 6
Phenoxymethylpenicillin should be used if Group A beta-hemolytic streptococci are isolated, according to the British Medical Journal 5, 6
Erythromycin is appropriate for patients with penicillin allergy or when resistance to flucloxacillin is identified, as stated by the British Medical Journal 5, 6

Antibiotics should be administered alongside standard atopic dermatitis treatment, including topical steroids, as recommended by the American Academy of Dermatology 1, 2
Systemic antiviral therapy (acyclovir) is the mainstay of treatment for the primary HSV infection in eczema herpeticum, with the American Academy of Dermatology and the British Medical Journal emphasizing its importance 2, 5
Early initiation of antiviral therapy is crucial and correlates with reduced length of hospital stay and better outcomes, as indicated by the American Academy of Dermatology 2, 8
In ill, febrile patients, intravenous acyclovir should be given rather than oral therapy, as recommended by the British Medical Journal 5, 6

The recommendations are based on clinical guidelines from reputable dermatology organizations, with the American Academy of Dermatology guidelines from 2014 representing the most recent comprehensive guidance on this topic 1, 2